Filing Details

Accession Number:
0000899243-19-004464
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-21 19:51:27
Reporting Period:
2019-02-19
Accepted Time:
2019-02-21 19:51:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1631574 Wave Life Sciences Ltd. WVE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1657710 Paul Bolno C/o Wave Life Sciences Ltd.,
733 Concord Ave.
Cambridge MA 02138
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2019-02-19 7,614 $36.38 271,328 No 4 S Direct
Ordinary Shares Disposition 2019-02-19 119 $37.47 271,209 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. On February 19, 2019, the reporting person sold 7,733 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2019. These sales were made pursuant to a 10b5-1 Trading Plan.
  2. The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $37.4638 to $37.4672 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.